A Drosophila model for Src-mediated oncogenesis

Src 介导的肿瘤发生的果蝇模型

基本信息

项目摘要

Cancer is the second most common source of mortality in this country and solid tumors account for 90% of all cancers. They are a primary target for drug therapeutics but success has been limited in bringing long-term cure or remission. To achieve this elusive goal, further work is needed to understand the complexity of cancer, which is a multigenic disease with the ability to 'adapt' to treatment. 90% of cancer deaths are due to metastasis and this is becoming an increasing focus of cancer research. A fundamental difficulty of cancer is its complexity: it is typically a multigenic disease with extensive in situ crosstalk. Successful drug screens will need to account for these whole animal aspects of efficacy. To date, however, most whole animal compound screens are too expensive to achieve at a reasonable throughput. This proposal describes a whole animal approach to cancer progression utilizing the fruit fly Drosophila. It focuses on single and multigenic models generated through activation of Src either directly or through reduced activity of its major negative regulator Csk. Data is presented supporting a novel model of metastasis in which local signals from neighboring epithelial cells provoke release and metastasis of transformed cells from the outer border of tumors. Evidence is presented for similar molecular events occurring in human squamous cell carcinomas. This proposal explores the nature of these signals by examining how high Src activity acts in synergy with RTK/Ras signaling. In addition, this Proposal seeks to establish a novel model of tumorigenesis by generating discrete adult 'tumors'. This latter model is designed to identify genes that direct mature tumors and drugs that reverse rather than prevent them. Finally, this proposal proposes to expand our efforts in candidate drug discovery. We will expand our initial efforts eight-fold by screening a large private compound library with an emphasis on 'druggable' compounds. Hits will be further assessed by multiple secondary assays and further studies such as initial structure/activity relationship analysis will be pursued. The goal is to define useful chemical space as well as complement our genetic efforts towards identifying mechanisms and therapeutic targets that address overgrowth and metastasis.
癌症是这个国家第二大最常见的死亡原因,其次是实体瘤

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
KIF5B-RET Oncoprotein Signals through a Multi-kinase Signaling Hub.
  • DOI:
    10.1016/j.celrep.2017.08.037
  • 发表时间:
    2017-09-05
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Das TK;Cagan RL
  • 通讯作者:
    Cagan RL
Drosophila cancer models.
  • DOI:
    10.1002/dvdy.22771
  • 发表时间:
    2012-01
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Rudrapatna, Vivek A.;Cagan, Ross L.;Das, Tirtha K.
  • 通讯作者:
    Das, Tirtha K.
Drosophila as a tool for personalized medicine: a primer.
果蝇作为个性化医学的工具:底漆。
  • DOI:
    10.2217/pme.10.65
  • 发表时间:
    2010-11
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Kasai Y;Cagan R
  • 通讯作者:
    Cagan R
Drosophila Cancer Models Identify Functional Differences between Ret Fusions.
  • DOI:
    10.1016/j.celrep.2016.08.019
  • 发表时间:
    2016-09-13
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Levinson S;Cagan RL
  • 通讯作者:
    Cagan RL
Non-mammalian models of multiple endocrine neoplasia type 2.
  • DOI:
    10.1530/erc-17-0411
  • 发表时间:
    2018-03
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Das TK;Cagan RL
  • 通讯作者:
    Cagan RL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ross Leigh Cagan其他文献

Ross Leigh Cagan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ross Leigh Cagan', 18)}}的其他基金

A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
探索结直肠癌新治疗空间的化学遗传学方法
  • 批准号:
    10908073
  • 财政年份:
    2023
  • 资助金额:
    $ 27.85万
  • 项目类别:
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
探索结直肠癌新治疗空间的化学遗传学方法
  • 批准号:
    10359839
  • 财政年份:
    2021
  • 资助金额:
    $ 27.85万
  • 项目类别:
A Cytochrome P450 Therapeutic Space for Tauopathies
Tau蛋白病的细胞色素 P450 治疗空间
  • 批准号:
    10461317
  • 财政年份:
    2021
  • 资助金额:
    $ 27.85万
  • 项目类别:
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
探索结直肠癌新治疗空间的化学遗传学方法
  • 批准号:
    10182641
  • 财政年份:
    2021
  • 资助金额:
    $ 27.85万
  • 项目类别:
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
探索结直肠癌新治疗空间的化学遗传学方法
  • 批准号:
    10600844
  • 财政年份:
    2021
  • 资助金额:
    $ 27.85万
  • 项目类别:
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models
利用复杂果蝇和哺乳动物模型的新疾病平台
  • 批准号:
    9306960
  • 财政年份:
    2015
  • 资助金额:
    $ 27.85万
  • 项目类别:
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models
利用复杂果蝇和哺乳动物模型的新疾病平台
  • 批准号:
    9118383
  • 财政年份:
    2015
  • 资助金额:
    $ 27.85万
  • 项目类别:
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)
将饮食引起的肥胖与癌症联系起来的果蝇模型 (PQ 1)
  • 批准号:
    8383704
  • 财政年份:
    2012
  • 资助金额:
    $ 27.85万
  • 项目类别:
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)
将饮食引起的肥胖与癌症联系起来的果蝇模型 (PQ 1)
  • 批准号:
    8870186
  • 财政年份:
    2012
  • 资助金额:
    $ 27.85万
  • 项目类别:
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)
将饮食引起的肥胖与癌症联系起来的果蝇模型 (PQ 1)
  • 批准号:
    8677826
  • 财政年份:
    2012
  • 资助金额:
    $ 27.85万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.85万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了